Please Wait...

J. Michael O'Neal

Translation skills

Main profile

J. Michael O'Neal, M.D.
J. Michael O'Neal, M.D.
Chief Medical Officer, Head of Oncology

As the Chief Medical Officer at Bioclinica, Dr. O'Neal provides leadership to all on-staff radiologists and external radiology consultants, manages the organizational planning and operational needs of Bioclinica's Medical Affairs department, and oversees physician training, service quality, and process improvements.

Dr. O'Neal is a graduate of Rutgers University and earned his M.D. at the Universidad Autonoma de Guadalajara. He has over 20 years of experience with extensive clinical training in internal medicine and diagnostic radiology including an imaging fellowship at St. Barnabas Medical Center. In addition to oversight of imaging data in support of regulatory approval for many oncology drugs, Dr. O'Neal has participated in protocol review, charter development, and independent review for nearly 300 clinical trials to date.

Dr. O'Neal holds certifications from the American Board of Radiology and the American College of Radiology and is a member of many professional organizations, including the Radiological Society of North America (RSNA), the American College of Radiology (ACR), the American Medical Association (AMA), the Drug Information Association (DIA), the American Society for Clinical Oncology (ASCO), and the American Society of Hematology (ASH). Prior to joining Bioclinica, he served as the Chairman for the Department of Radiology at the Hospital Center at Orange, as the Vice President of Medical Affairs at RadPharm, and as the Chief Medical Officer at Core Lab Partners.

Authored Publications

Van Heertum RL, Scarimbolo R, Ford R, Berdougo E, O’Neal M. Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials. Drug Design, Development and Therapy 2015:9 5215–5223.

Blogs

Rapid advances in imaging and cancer biomarkers are helping to shift treatments from cytotoxic to molecularly targeted therapies, necessitating modifications to conventional anatomical response criteria.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great #SCOPE2019 panel discussion today with industry veterans sharing ways sponsors and vendors can work together… https://t.co/U8j40R6y6R
Bioclinica (3 hours ago)
RT @teaminspire: Patients Are Eager for Trials But Aren’t Getting the Word, Survey Finds https://t.co/BfLxhmpzZg via @CenterWatch #clinical…
Bioclinica (9 hours ago)
RT @DrugInfoAssn: Didn’t make it to #DIAEurope2019 in Vienna? Read highlights from @EFPIA here: https://t.co/I1XYJkTBha
Bioclinica (9 hours ago)
RT @CDISC: Introducing the CDISC Library https://t.co/KsGqdqIZBO. Join the CDISC Data Science team for two informational webinars to accomm…
Bioclinica (9 hours ago)
RT @PhillyCooke: Reminder that @RAPSorg Philly chapter networking mixer is March 7 at @DePuySynthes in West Chester. Register now: https://…
Bioclinica (10 hours ago)
RT @FDAWomen: #BlackHistoryMonth is also #HeartMonth. With 48% of African American women having a form of cardiovascular disease, it is tim…
Bioclinica (10 hours ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box